Cargando…

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance

Vildagliptin is one of the most extensively studied dipeptidyl peptidase-4 (DPP-4) inhibitors in terms of its clinical utility. Over the last decade, a vast panorama of evidence on the benefit–risk profile of vildagliptin has been generated in patients with type 2 diabetes mellitus (T2DM). In this a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathieu, Chantal, Kozlovski, Plamen, Paldánius, Päivi M, Foley, James E, Modgill, Vikas, Evans, Marc, Serban, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Touch Medical Media 2017
Materias:	Type 2 Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813467/ https://www.ncbi.nlm.nih.gov/pubmed/29632610 http://dx.doi.org/10.17925/EE.2017.13.02.68

Ejemplares similares

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
por: Foley, James E, et al.
Publicado: (2017)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus
por: Evans, Marc, et al.
Publicado: (2017)

Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross‐over randomised controlled trial
por: Sanders, L. M., et al.
Publicado: (2020)

Substitution among milk and yogurt products and the risk of incident type 2 diabetes in the EPIC‐NL cohort
por: Stuber, J. M., et al.
Publicado: (2020)

Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies
por: Kozlovski, Plamen, et al.
Publicado: (2017)

Beta-cell Insufficiency
por: Kalra, Sanjay, et al.
Publicado: (2017)

Research: Treatment Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard-of-care metformin monotherapy—the VERIFY trial: a randomized double-blind trial
por: Del Prato, S, et al.
Publicado: (2014)

Genetic Risk of Progression to Type 2 Diabetes and Response to Intensive Lifestyle or Metformin in Prediabetic Women With and Without a History of Gestational Diabetes Mellitus
por: Sullivan, Shannon D., et al.
Publicado: (2014)

The Reality of Type 2 Diabetes Prevention
por: Kahn, Richard, et al.
Publicado: (2014)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

A “Spoonful of Sugar” and the Realities of Diabetes Prevention!
por: Cefalu, William T.
Publicado: (2014)

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
por: Bress, Adam P., et al.
Publicado: (2018)

Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
por: Lamprea-Montealegre, Julio A., et al.
Publicado: (2018)

Prevalence of different states of glucose intolerance in Sri Lankan children and adolescents with obesity and its relation to other comorbidities
por: Ciba, Iris, et al.
Publicado: (2020)

Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes?: Health Be Damned! Pour on the Sugar
por: Bray, George A., et al.
Publicado: (2014)

Household food insecurity is associated with diabetic ketoacidosis but not severe hypoglycemia or glycemic control in youth and young adults with youth‐onset type 2 diabetes
por: Reid, Lauren A., et al.
Publicado: (2022)

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes
por: Barrientos‐Pérez, Margarita, et al.
Publicado: (2022)

Extended family history of type 1 diabetes in HLA‐predisposed children with and without islet autoantibodies
por: Kuusela, Salla, et al.
Publicado: (2020)

Mixed‐meal tolerance test to assess residual beta‐cell secretion: Beyond the area‐under‐curve of plasma C‐peptide concentration
por: Ruan, Yue, et al.
Publicado: (2019)

Insulin Glulisine in Pregnancy – Experience from Clinical Trials and Post-marketing Surveillance
por: Doder, Zoran, et al.
Publicado: (2015)

Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol
por: Yeu, Rui Qian, et al.
Publicado: (2020)

Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus
por: Panneerselvam, P, et al.
Publicado: (2023)

Personal Education Programme in Sweden
por: Muoi, Nguyen Thi
Publicado: (1999)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Flow Cytometry”: Guest Editor for the “Flow cytometry” issue: Katherina Psarra
Publicado: (2019)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Improving the Preanalytical Phase in Laboratory Medicine”: Guest Editor for the “Pre-analytical phase” issue: Gabriel Lima-Oliveira
Publicado: (2019)

Request for Nominations for Members for the Committee on Laboratory Management of the Education and Management Division of IFCC
por: Wilkinson, I.
Publicado: (2003)

Past Lives
por: Williams, David L.
Publicado: (2003)

Development of Reference Methods and Reference Materials by the IFCC: An Overview
por: FOREST, JEAN-CLAUDE, et al.
Publicado: (2001)

IFCC Professional Scientific Exchange Programme (PSEP) Report: Plasma Protein Separation Techniques: Ishmael Kasvosve, Zimbabwe: - Report on Scientific Visit
por: Kasvosve, Ishmael
Publicado: (2000)

Clinical Chemistry Question and Answer
por: Apple, Fred S.
Publicado: (1999)

Clinical Chemistry Question and Answer
Publicado: (1999)

IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation
Publicado: (1999)

Visiting lecturer report
por: Siest, G.
Publicado: (2000)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Measurably Better Healthcare”
por: Dow, Ellie, et al.
Publicado: (2020)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Laboratory Aspects of COVID-19 Disease”
Publicado: (2021)

Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes
por: Poynard, Thierry, et al.
Publicado: (2021)

Diabetic Foot Ulcers and Vitamin D Status: A Literature Review
por: Macido, Antony
Publicado: (2018)

Linguistic and Psychometric Validation of the Thai Version of Simplified Diabetes Knowledge Scale: A Measure of Knowledge of Diabetes in a Thai Population
por: Khunkaew, Saneh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u5lnqm114l57q7u18cl5gaqe05